Our group has been a pioneer in this field and engineered cancer cells to constitutively express Gaussia luciferase and conditionally express Firefly luciferase in response to either BMP signaling activation [37] or TGF-β signaling activation [38]. This evidence concerns the gene TGFB1 and cancer.